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Abstract
Oxysterols are oxidation products of cholesterol that are generated by enzymatic reactions mediated by
cytochrome P450 family enzymes or by non-enzymatic reactions involving reactive oxygen and nitrogen species.
Oxysterols play various regulatory roles in normal cellular processes such as cholesterol homeostasis by acting as
intermediates in cholesterol catabolism. Pathological effects of oxysterols have also been described, and various
reports have implicated oxysterols in several disease states, including atherosclerosis, neurological disease, and
cancer. Numerous studies show that oxysterols are associated with various types of cancer, including cancers of
the colon, lung, skin, breast and bile ducts. The molecular mechanisms whereby oxysterols contribute to the
initiation and progression of cancer are an area of active investigation. This review focuses on the current state of
knowledge regarding the role of oxysterols in carcinogenesis. Mutagenicity of oxysterols has been described in
both nuclear and mitochondrial DNA. Certain oxysterols such as cholesterol-epoxide and cholestanetriol have been
shown to be mutagenic and genotoxic. Oxysterols possess pro-oxidative and pro-inflammatory properties that can
contribute to carcinogenesis. Oxysterols can induce the production of inflammatory cytokines such as interleukin-8
and interleukin-1b. Certain oxysterols are also involved in the induction of cyclo-oxygenase-2 expression.
Inflammatory effects can also be mediated through the activation of liver-X-receptor, a nuclear receptor for
oxysterols. Thus, several distinct molecular mechanisms have been described showing that oxysterols contribute to
the initiation and progression of cancers arising in various organ systems.
Introduction
Oxysterols are derived from either enzymatic or non-enzy-
matic oxidation of cholesterol [1,2]. The chemical struc-
tures of oxysterols vary depending upon the number and
position of oxygenated functional groups, and include
keto-, hydroxyperoxy-, and epoxy forms (Figure 1). Enzy-
matic pathways of oxysterol production mainly involve
cytochrome P450 family enzymes. Examples include 27-
hydroxylase (CYP27A1), the key enzyme in the alternative
bile acid synthesis pathway which leads to the production
of 27-hydroxycholesterol [3,4]; and 7a-hydroxylase
(CYP7A), the rate limiting enzyme in the classical bile acid
synthesis pathway that leads to the production of 7a-
hydroxycholesterol [3,5]. Certain oxysterols are produced
by non-enzymatic oxidation (or auto-oxidation), a process
that involves reactive oxygen and nitrogen species (ROS,
RNS). Examples of ROS that participate in non-enzymatic
oxidation of cholesterol include hydroxyl radical (
.OH),
hydrogen peroxide (H2O2), singlet oxygen (
1O2) and ozone
(O3) [6,7]. 7a-hydroperoxycholesterol is an example of a
product of non-enzymatic oxidation of cholesterol which
can be further oxidized by non-enzymatic and enzymatic
means. Examples of oxysterols generated by this mechan-
ism are 7-ketocholesterol and 7a/b-hydroxycholesterol.
Numerous in vivo and in vitro studies have described
biological effects of oxysterols [5]. Oxysterols can act as
intermediates in cholesterol catabolism, especially in bile
acid synthesis and are therefore involved in the elimina-
tion of excess cholesterol from the body. As oxysterols
possess more hydrophilic moieties compared to the parent
cholesterol molecule, they can pass more easily through
cell membranes. This can occur because polar moieties
inserting into hydrophobic regions of cell membranes
result in redistribution of the sterol in conjunction with
local re-ordering of the acyl chains [3,8,9]. Oxysterols are
also able to regulate key enzymes in cholesterol turnover
such as 3-hydroxy-3-methylglutaryl (HMG)-coenzyme A
(CoA) reductase [10], the rate-limiting enzyme in choles-
terol synthesis.
Pathogenic effects of oxysterols has been described
predominantly in cardiovascular diseases [6,11,12] and
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any medium, provided the original work is properly cited.degenerative diseases such as age-related macular degen-
eration [13], Alzheimer’s disease [14,15] and osteoporo-
sis [16]. Several reports report a role for oxysterols in
neurological disease (summarized in Table 1) [17-20].
The effects of cholesterol oxidation products on carcino-
genesis was first reported by Bischoff and Rupp in 1946
[21]. Ovariectomized mice that received 10 mg of crude
progesterone in sesame oil showed a higher incidence of
cancer than mice that received purified progesterone.
Cholesterol oxidation products were found in mice that
received the crude progesterone extract. This study pro-
vided circumstantial evidence that carcinogens may be
produced endogenously from cholesterol. Subsequent
studies have demonstrated the carcinogenic potential of
specific oxysterols. For example, 6b-hydroperoxy-4-choles-
tane-3-one injected subcutaneously led to the develop-
ment of local sarcomas in mice [22]. Cholesterol-5a,6 a-
epoxide also induced local sarcomas [23].
Role of oxysterols in tissue-specific carcinogenesis
Oxysterols and lung cancer
An epidemiological study described the relationship
between lung cancer risk and oxysterols. Using a nested
case-control study design, smoking-independent associa-
tions between cholesterol oxidation and lung cancer risk
were investigated. Six oxysterols (7a-hydroxycholesterol,
7b-hydroxycholesterol, cholesterol-a-epoxide, choles-
terol-b-epoxide, cholestanetriol, 7-ketocholesterol and 7-
keto-pregnenolone), were measured in plasma of 20
lung cancer patients. The results showed slightly
increased levels of all oxysterols compared with control
with the exception of 7a-hydroxycholesterol and choles-
terol-a-epoxide. Additionally, a risk analysis showed no
statistical significant link between oxysterol concentra-
tions and lung cancer development. When adjusted for
participation in sports, however, the association between
7b-hydroxycholesterol levels and lung cancer was statis-
tically significant. The data suggest that plasma levels of
7b-hydroxycholesterol are a smoking-independent pre-
dictor and biomarker for lung cancer risk [24]. Increased
levels of 7b-hydroxycholesterol may be caused by lipid
peroxidation, oxysterol dietary intake and individual dif-
ferences in the metabolism of oxysterols.
Several reports describe the anti-cancer effects of 7b-
hydroxycholesterol in lung cancer and various other types
of cancer [25-28]. 7b-hydroxycholesterol mediated a cyto-
toxic effect on human NCI-H460 lung cancer cells through
the induction of apoptosis via caspase activation [29].
Role of oxysterols in colon carcinogenesis
Several reports have provided evidence that oxysterols
contribute to gastrointestinal cancer development. Ani-
mal fat oxidation products, including oxysterols, have
been linked to colon carcinogenesis. One possible
mechanism for this effect is via upregulation of expres-
sion of transforming growth factor-b1( T G F - b1) in
macrophages and fibroblasts, cells which are present in
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Figure 1 Structure of cholesterol and several common oxysterols.
Table 1 Oxysterol disease associations
Oxysterols Cancer Atherosclerosis Neurological diseases References
5,6-cholesterolepoxide √√ [84,85]
Cholestane-3b,5a,6b-triol √√ [17,86,87]
25-hydroxycholesterol √ [88]
24-hydroxycholesterol √ [89-91]
7-Hydroperoxy-
cholesterols
√ [92]
7-hydroxycholesterol √ [93]
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involved in promoting differentiation and apoptosis in
intestinal epithelial cells. Colon cancer cells demonstrate
decreased expression of TGF-b1 type I and/or type II
receptors [31]. Thus, colon cancer cells are less suscepti-
ble to the growth regulatory effects of TGF-b1. An
increased concentration of TGF-b1 is thought to be
involved in a selective elimination of neoplastic cells
susceptible to the pro-apoptotic effects of this cytokine,
thereby indirectly allowing the clonal expansion of TGF-
b1-insensitive neoplastic cells [32,33]. Consequently, dis-
ruption of TGF-b1 growth inhibition would support
uncontrolled cell proliferation and transformation. Such
alterations in TGF-b1 receptor expression have been
described in cancers of the colon [34], prostate [35],
breast [36] and lung [37]. An oxysterol mixture com-
posed of 7a-hydroxycholesterol (43%), 5a,6 a-epoxycho-
lesterol (32%) and 5b,6 b-epoxycholesterol (6%) induced
apoptosis in the human colon adenocarcinoma cell line
CaCo-2. The mitochondrial pathway of apoptosis was
upregulated in these cells after stimulation by oxysterols
as shown by a decrease in mitochondrial membrane
potential, release of cytochrome c, and activation of cas-
pase-3. The mechanism of oxysterol-induced upregula-
tion of apoptosis in differentiated CaCo-2 cells involved
increased production of ROS by NADPH oxidase activa-
tion [38]. Excessive levels of ROS and pro-inflammatory
cytokines likely contribute to impairment of enteric
mucosal function [39].
Patients with ulcerative colitis are at risk for develop-
ing colon cancer. These patients excrete high levels of
cholesterol, coprostanol and cholestane-3b-5a-6b triol
(cholestanetriol) in feces compared to patients with
other digestive diseases and healthy controls [40]. How-
ever, the carcinogenic effect of oxysterols has not been
demonstrated in rat colons. No colonic tumors were
induced by sterols including cholesterol epoxide, choles-
tanetriol and cholesterol in standard and germ free
female rats. Only lithocolic acid, a bile acid produced by
bacterial oxidation of chenodeoxycholic acid in the
colon, induced colon cancer in this model [41].
Role of oxysterols in cholangiocarcinogenesis
Oxysterols may also play a role in the development and
progression of cholangiocarcinoma (CCA), a malignancy
arising from intra- and extra-hepatic bile duct epithelial
cells or cholangiocytes. A risk factor for the develop-
ment of CCA in Thailand is chronic infection with the
liver fluke, Opisthorchis viverrini [42,43]. Infection leads
to accumulation of nitric oxide (NO) and oxygen radi-
cals in inflamed tissue resulting in direct and indirect
DNA damage both in animal and human studies
[44-47]. We found significantly increased levels of 4-
cholesten-3-one and cholestanetriol in a hamster model
of CCA induced by liver fluke infection combined with
N-nitrosodimethylamine treatment (unpublished data).
Interleukin 6 (IL-6) is a potent mitogen for cholangio-
cytes and cholangiocarcinoma cells [48-50]. The role of
oxysterols in mediating tumo rf o r m a t i o ni nc h o l a n g i o -
cytes was reported by Yoon et. al.[51]. These investiga-
tors examined the effect of 22(R)-hydroxycholesterol
(22-HC) on cyclooxygenase-2 (COX-2) expression and
found that this oxysterol stabilized the level of COX-2
mRNA via a p38-mitogen activated protein kinase
(MAPK)-dependent mechanism leading to COX-2 pro-
tein accumulation in a CCA cell line. This induction of
COX-2 could promote cellular replication and inhibit
apoptosis [52] and thus contribute to the progression of
CCA. In addition to induction of COX-2 expression,
bile acids also enhance cellular levels of a potent anti-
apoptotic protein, myeloid cell leukemia protein 1 (Mcl-
1) [53]. Given the important role of apoptosis inhibition
in carcinogenesis and the dominant anti-apoptotic
effects of Mcl-1 in CCA cells, this observation may be
important in understanding the tropism displayed by
bile acid-induced CCA. Indeed, CCA appears to have
co-opted the toxic bile milieu to promote growth and
survival. Alteration of bile composition during chronic
inflammation warrants further investigation as a
mechanism of biliary tract carcinogenesis. This observa-
tion suggests that these tumors may not only have
developed mechanisms to survive the toxic constituents
in bile but may actually use bile to promote growth and
survival.
Oxysterols were found in infected human hepatic bile,
with 7a-hydroxycholesterol and 7b-hydroxycholesterol
present at significantly higher concentrations in infected
than in uninfected bile. The levels of 7a-hydroxycholes-
terol, 7b-hydroxycholesterol, cholestanetriol, 7-a-
hydroxy-4-cholestane-3-one and 7-ketocholesterol were
also positively correlated with C-reactive protein (CRP)
levels. These findings suggest that infection of biliary
cells may be linked to the synthesis of oxysterols and
consequently participate in the development of biliary
diseases [54,55].
Mechanisms of oxysterols in carcinogenesis
Mutagenicity of oxysterols
The mutagenic effects of oxysterols were first described
in1979. Smith et al. [56] reported this effect in air-aged
samples of cholesterol on five strains of Salmonella
typhimurium using the Ames method. Exposure of pure
cholesterol to heating in air at 70°C or to 60°C or
g-radiation resulted in the genesis of mutagenic com-
pounds. No mutagenic effect of cholesterol-a-epoxide
and cholesterol-b-epoxide was shown, similar to choles-
terol. In a hamster model, cholesterol-a-epoxide showed
a weak mutagenic effect. V79 Chinese hamster lung
fibroblasts treated with cholesterol-a-epoxide induced
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4.6 to 11.8-fold higher than the spontaneous mutation
rate in rats. Cholesterol-a-epoxide accumulates in cells
and can transform into cholestanetriol which possesses
greater cytotoxicity and acts as a potent inhibitor of
DNA synthesis. This modification causes a decrease in
the mutagenic effects of cholesterol-a-epoxide. Thus the
mutagenicity of cholesterol-a-epoxide in V79 Chinese
hamster lung fibroblast cells may depend on the ability
of cell to metabolize cholesterol-epoxide to cholestane-
triol via epoxide hydrolase activity.
The genotoxicity of cholestanetriol using the Ames
method and the generation of chromosomal aberrations
has been demonstrated. Cholestanetriol, but not 7-keto-
cholesterol and cholesterol-5a-6a-epoxide, exhibited
genotoxicity as determined by the rate of bacterial rever-
tants in the absence of the metabolic activating enzyme
(S9). In addition, cholestanetriol induced chromosomal
aberrations in Chinese hamster ovary cells (CHO-K1) in
the presence and absence of the S9 fraction. However,
the degree of abnormalities in chromosomal structure
was reduced with S9 treatment when compared to no
treatment. Anti-oxidant enzymes including catalase and
superoxide dismutase can inhibit cholestanetriol-induced
increases in bacterial revertant rates and chromosome
aberration in CHO-K1 cells. ROS production also
increased in cholestanetriol-treated cells. These results
suggest that genotoxicity of cholestanetriol may involve
ROS generation [57]. Moreover, the effect of oxysterols
on DNA mutation was reported by Gramajo et al.[58].
7-ketocholesterol-treated culture significantly increased
the degree of mitochondrial DNA (mtDNA) damage in
the human RPE cell line (ARPE-19). Various studies
also provide evidence that oxysterols enhance the pro-
duction of ROS/RNS [57-62]. Oxysterols might enhance
the production of ROS/RNS through alterations in the
mitochondrial electron transport chain [59].
Role of oxysterols in oxidative stress and inflammation
Numerous studies have found a role for oxysterols in
mediating pro-oxidative and pro-inflammatory processes
in age-related degenerative diseases such as Alzheimer’s
disease and atherosclerosis [6,13,63,64]. The pro-oxida-
tive and pro-inflammatory effect of 7a-, 7b-hydroxycho-
lesterol, 7-ketocholesterol, cholesterol-5a-6a-epoxide,
cholesterol-b-epoxide, 22R-, 22S-, 25- and 27-hydroxy-
cholesterol were studied in U937 human promonocytic
leukemia cells. 7b-hydroxycholesterol, 7-ketocholesterol
and cholesterol-b-epoxide increased the production of
singlet oxygen. The highest capacity to stimulate IL-8
secretion and enhance IL-8 mRNA levels was observed in
cells treated with 7b-hydroxycholesterol and 25-hydroxy-
cholesterol [18]. Oxysterols that were oxidized at C7
enhanced the production of free radicals [62,65,66]. 7-
ketocholesterol caused a decrease in cellular glutathione
content, oxidation of polyunsaturated fatty acids and
enhanced the production of ROS [62]. Moreover, 7-keto-
cholesterol enhanced IL-1b secretion in endothelial cells
and participated in the recruitment of monocytes and T
lymphocytes.
The cytotoxicity of 7-ketocholesterol and 7b-hydroxy-
cholesterol involves induction of oxidative stress and
down-regulation of anti-oxidative mechanisms [62].
These effects can be inhibited by anti-oxidant com-
pounds such as lycopene, carotene, folate, glutathione,
N-acetylcysteine and resveratrol [64,65,67-70]. Notably,
the pro-oxidative and cytotoxic effects may occur in the
absence of activation of NADPH oxidase, as shown in
J774A.1 macrophage cells [60,71]. NADPH oxidase plays
a key role in oxysterol-induced ROS production in a
human colon adenocarcinoma cell line [38].
Pro-inflammatory effects of oxysterols have also been
described. 7-ketocholesterol, 7b-hydroxycholesterol, 24-
hydroxycholesterol, 25-hydroxycholesterol and cholesta-
netriol have the capability to induce IL-8 production.
The pro-inflammatory effects of 25-hydroxycholesterol
was increased in hypoxic culture conditions and poten-
tiated lipopolysaccharide (LPS)-induced IL-1b secretion
[72]. In U937 and THP-1 cells, 7b-hydroxycholesterol
and 25-hydroxycholesterol were involved in the recruit-
ment of immunocompetent cells via MCP-1, MIP-1b,
TNF-a, IL-1b and IL-8 [73]. In addition, certain oxyster-
ols are involved in the induction of COX-2 expression
which correlates with CRP levels [51,55].
Pro-inflammatory effects of oxysterols also act at the
transcriptional level. This can involve the activation of
the liver-X-receptor (LXR) which is a nuclear receptor
for certain oxysterols [74]. Pro-inflammatory oxysterols
that exert their effect through LXR include 22R-hydroxy-
cholesterol and 25-hydroxycholesterol but not 7b-hydro-
xycholesterol [19]. 7b-hydroxycholesterol appears to
exert its pro-inflammatory effects at translational and
post-translational levels. In 7b-hydroxycholesterol-trea-
ted U937 and THP-1 cells, increased IL-8 secretion was
found. This activation is associated with activation of the
MEK/ERK1/2 signaling pathway [73]. The anti-inflamma-
tory effects of oxysterols were also described in human
macrophages incubated with 7-ketocholesterol, 7b-
hydroxycholesterol, 25-hydroxycholesterol and 27-hydro-
xycholesterol before exposure to LPS-induced TNF-a
secretion [75]. The 25-hydroxycholesterol which was
produced from the stimulation of macrophage toll-like
receptors (TLRs) can suppress IL-2-mediated stimulation
of B cell proliferation and block IgA class switch recom-
bination, resulting in decreased IgA production [76].
Oxysterol signaling pathways
Oxysterols may exert their cellular effects by binding to
specific proteins and activating signaling cascades. In
human breast cancer (MCF-7) cells, Silva et al. [77]
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human osteoblast-like MG63 cell-conditioned medium
(MG63CM) induced MCF-7 cell migration to bone tis-
sue. Interestingly, insulin-like growth factor 1 increased
the expression of oxysterol binding protein-related pro-
tein 7 (ORP7) in MCF-7 cells. Binding between these
ligands and receptors altered the organization of lipid
microdomains in cell membranes. Several oxysterol-
binding proteins such as ORP7 and ORP 3 were recently
reported to play a role in cell adhesion and migration
through R-Ras, a small GTPase [78]. ORP3 is abun-
dantly expressed in leukocytes and epithelial cells, and
abnormally high expression levels are found in leuke-
mias and solid tumors [79]. Oxysterol-binding protein-
like-8 is overexpressed in hamster induced cholangiocar-
cinoma [80].
Oxysterols may act as secondary messengers in signaling
transduction pathways. 22R-hydroxycholesterol stabilizes
COX-2 mRNA via the 38-MAPK pathway in human cho-
langiocytes [51]. Hepatocellular carcinoma cells HepG2
and Huh7 senesce via alteration of p38 MAPK when trea-
ted with 5,6 secosterol [81]. Moreover, bile acids, which
can be considered a type of oxysterol in bile, are known to
activate various signaling cascades. Bile acids can stimulate
cell proliferation by activation of the phosphatidylinositol-
3-kinase (PI3-K) pathway via a number of mitogen
receptor tyrosine kinases such as epidermal growth factor
receptor (EGFR) [82]. This activation is mediated by TGF-
a, which is a ligand for EGFR. Bile acids that transactivate
EGFR through a TGF-a dependent mechanism can be
blocked by matrix metalloproteinase (MMP) inhibitors.
This suggests that bile acids may activate the release of
TGF-a through the induction of MMP. The simplest
interpretation of this finding is that bile acids induce
MMP activity by generating soluble TFG-a leading to acti-
vation of EGFR (Figure 2). Rats with obstructed bile ducts
demonstrate increased cholangiocyte proliferation and
secretion [83].
Conclusions
This review focuses on the mechanisms that may be
operative in oxysterol-induced or associated carcinogen-
esis. In vitro and in vivo studies have demonstrated an
association between different types of oxysterols and the
development and progression of cancer of the colon,
lung, breast and bile ducts. Oxysterols may play critical
r o l e si nm u l t i p l es t a g e so fc a r c i n o g e n e s i s( F i g u r e3 ) .
First, they may be involved in tumor initiation by
enhancing the production of ROS/RNS. Second, tumor
promotion may be enhanced by oxysterols through
upregulated expression of proteins such as COX-2 lead-
ing to the alteration of cellular phenotypes. In addition,
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Figure 2 Bile acids transactivate EGFR in cholangiocytes. Bile acids induce a signaling transduction cascade through EGFR. Bile acids can
stimulate Src kinase activity, enhance MMP activity and generate TGF-a. Soluble TGF-a acts as the ligand for activation of EGFR. This activation
induces signaling molecules such as protein kinase C (PKC), PI3-K and MAPK resulting in alterations in the cell cycle, cell growth, and cell survival
(adapted from [53].
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through the induction of migration. Oxysterols may
exert their effect by binding to specific proteins and
activating signaling cascades. Further investigations of
oxysterols and their impact on carcinogenesis are
required for developing improved strategies for the pre-
vention and treatment of various types of cancer.
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